BICYCLE THERAPEUTICS PLC - BCYC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 04, 2026 | SCHEDULE 13G/A | Westfield Capital Management Company, L.P. | 0.0% | — | View |
| Mar 03, 2026 | SCHEDULE 13G | Invus Public Equities, L.P. | 5.4% | 2,719,707 | View |
| Mar 03, 2026 | SCHEDULE 13G | Invus Public Equities Advisors, LLC | 5.4% | 2,719,707 | View |
| Mar 03, 2026 | SCHEDULE 13G | Invus Global Management, LLC | 5.4% | 2,719,707 | View |
| Mar 03, 2026 | SCHEDULE 13G | Siren, L.L.C. | 5.4% | 2,719,707 | View |
| Mar 03, 2026 | SCHEDULE 13G | Avicenna Life Sci Master Fund LP | 0.9% | 429,342 | View |
| Mar 03, 2026 | SCHEDULE 13G | Avicenna Life Sci Master GP LLC | 0.9% | 429,342 | View |
| Mar 03, 2026 | SCHEDULE 13G | Ulys, L.L.C. | 0.9% | 429,342 | View |
| Mar 03, 2026 | SCHEDULE 13G | Raymond Debbane | 6.3% | 3,149,049 | View |
| Mar 03, 2026 | SCHEDULE 13G/A | Westfield Capital Management Company, L.P. | 0.0% | 0 | View |
| Mar 03, 2026 | SCHEDULE 13G/A | Westfield Capital Management Company, L.P. | 0.0% | 0 | View |
| Feb 18, 2026 | SCHEDULE 13G | Armistice Capital, LLC | 6.48% | 3,236,000 | View |
| Feb 18, 2026 | SCHEDULE 13G | Steven Boyd | 6.48% | 3,236,000 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Westfield Capital Management Company, L.P. | 6.04% | 3,016,026 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.